AZN vs MDT · P/E 28, $288.38B cap vs P/E 21, rev $36.36B
AstraZeneca PLC (AZN) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Medtronic PLC (MDT) is a medical devices company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the AZN and MDT stock pages for the full models.
Not investment advice.